Manvi Biopharma Pvt. Ltd. Walk In Interview for QC, R&D & QA, Warehouse, Human Resource, EHS on 12th & 14th Dec’ 2022
WALK IN-INTERVIEW
MANVI BIOPHARMA PRIVATE LIMITED
We are looking for the following professionals for our Manufacturing Unit, QC, R&D & QA Urgent Requirement)
Department : Quality Control, Quality Assurance, Warehouse, Human Resource, EHS, R&D
Designation : Chemist / Sr.Chemist/ Executive
Experience : 1-5 Years
Vacancies : 46 positions
Qualification : B.Sc Chemistry/ M.Sc Organic Chemistry
Work location Manufacturing site : Fugen Laboratories Pvt. Ltd (A subsidiary of Manvi Biopharma Pvt. Ltd), Mandollagudem (V), Choutuppal (M).
Yadadribhuvanagiri (Dt)-508 252. Telangana state. India.
Date & Time of Walk in : 12th & 14th Dec’ 2022
(10:00 am-03:00 pm)
Interview Venue : Manvi Biopharma Pvt. Ltd. Plot #186 B, IDA, Mallapur, Hyderabad-500 076, Telangana State. India
Fresher’s 2021/2022 Passed out only Eligible
Salary will not be a constraint for deserving candidates
Contact No: 9951015911,9154775242 &7799227713
(Email id: [email protected]) & [email protected]
Please Note: Candidates are requested to bring updated resume, Photo copies of all educational certificates, Latest increment latter, Last three months’ pay slips/Last three Months bank statement & Aadhar card copy.
Company website : www.ManviBiopharma.com
Similar Post..
Macleods Pharmaceutical Walk-In Drive at Indore for Baddi & Sikkim Location on 16th December 2022
- APL Healthcare Limited – Walk-In Drive for Production & Packing Roles (Technical Assistants, Executives) on 11th May 2025
- Sun Pharma Invites B.Pharm/M.Pharm Candidates for MS&T (Injectables) Roles – Walk-In on 11th May 2025, Vadodara
- Zuventus Healthcare Hiring: Quality Assurance Executive Position Open
- Ipca Hiring Research Scientists – Walk-In on 31st May 2025 (Mumbai) | Formulation & Development Roles
- Ipca Laboratories QC Department Hiring(freshers & experts) : Apply Now for Officer & Technician Roles
- FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
- Granules India Walk-In Interview on 14 May 2025 for API Production & SRS Roles
- FDA approves nivolumab with ipilimumab for unresectable or metastatic MSI-H or dMMR colorectal cancer
- Glenmark receives ANDA approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC)
- FDA Announces Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities
- Vital Therapeutics Freshers & Experts walk in for RO/DM Plant Operators, & Production Chemists | 10th May
- IDRS Labs Walk-In Interview for Analytical Development – 10 May 2025
